We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Elevated Methylthioadenosine Levels Linked to Poor Sepsis Prognosis

By LabMedica International staff writers
Posted on 23 Mar 2017
Print article
Image: Bacteria (yellow) interact with a human white blood cell. If left unchecked, this encounter might develop into sepsis (Photo courtesy of the NIAID).
Image: Bacteria (yellow) interact with a human white blood cell. If left unchecked, this encounter might develop into sepsis (Photo courtesy of the NIAID).
A recent study showed that methylthioadenosine, substrate of the methionine salvage pathway, was a regulator of sepsis that could accurately predict prognosis in patients.

Sepsis is a life-threatening condition that arises when the body's response to infection injures its own tissues and organs. Common signs and symptoms include fever, increased heart rate, increased breathing rate, and confusion. There also may be symptoms related to a specific infection, such as a cough with pneumonia, or painful urination with a kidney infection. In the very young, old, and people with a weakened immune system, there may be no symptoms of a specific infection and the body temperature may be low or normal, rather than high. Severe sepsis is sepsis causing poor organ function or insufficient blood flow. Septic shock is low blood pressure due to sepsis that does not improve after reasonable amounts of intravenous fluids are given. The risk of death from sepsis is as high as 30%, from severe sepsis as high as 50%, and from septic shock as high as 80%.

Reliable sepsis biomarkers could improve diagnosis, prognosis, and treatment. Towards this end, investigators at Duke University integrated human genetics, patient metabolite and cytokine measurements, and testing in a mouse model to demonstrate that the intracellular recycling system known as the methionine salvage pathway was a regulator of sepsis that could accurately predict prognosis in patients. Measurement of the pathway’s substrate, methylthioadenosine (MTA), in two cohorts of sepsis patients demonstrated increased plasma MTA in non-survivors. Plasma MTA was correlated with levels of inflammatory cytokines, indicating that elevated MTA marked a subset of patients with excessive inflammation.

The investigators reported in the March 8, 2017, online edition of the journal Science Advances that measurement of MTA was approximately 80% accurate in predicting death, which was comparable to the APACHE II (Acute Physiology and Chronic Health Evaluation II) score. APACHE II factors in the person's age, underlying condition, and various physiologic variables to yield estimates of the risk of dying of severe sepsis. Of the individual covariates, the severity of underlying disease most strongly influences the risk of dying.

In an in vivo study, mice infected with Salmonella were found to have prolonged survival times when MTA was administered before infection, suggesting that manipulating MTA levels could regulate the severity of the inflammatory response.

"It gets very complicated very fast," said senior author Dr. Dennis C. Ko, assistant professor of molecular genetics and microbiology at Duke University. "Some people might have too robust of an inflammatory response, some people might not have a robust enough response, and as a result their MTA levels will differ, both between individuals and within an individual over the course of an illness. Biomarkers could determine where individuals fall along that continuum, and what treatments might work."

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.